neoadjuvant nivolumab chemotherapy in resectable nsclc | dr. pradip kumar mondal | crsf 2023
Published 5 months ago • 15 plays • Length 6:45Download video MP4
Download video MP3
Similar videos
-
7:51
neoadjuvant durvalumab chemo: surgical outcomes in resectable nsclc | dr. shubham garg | crsf
-
7:08
dr sudeep das | neoadjuvant nivolumab plus platium doublet chemotherapy vs chemo for resectable
-
5:52
first-line selpercatinib chemotherapy pembrolizumab in ret nsclc | dr. pradeep ventrapati | crsf
-
7:37
dr. pradip mondal - 5th lung cancer year end review 2021- a step toward personalized nsclc treatment
-
20:53
expert panel discussion: advancements in lung cancer treatment | crsf 2023 year end review
-
2:27
study finds neoadjuvant nivolumab to show long-term benefit in patients with nsclc
-
17:18
crsf 07th masterclass in lung cancer | dr. mounika boppana on neoadjuvant io in advanced nsclc
-
5:45
dr bhavesh poladia | nivolumab chemotherapy vs chemotherapy as nat in resectable stage iii
-
2:39
neoadjuvant nivolumab with or without chemotherapy in resectable nsclc
-
9:53
crsf | dr. madala ravikrishna: neoadjuvant & adjuvant immunotherapy in early stage lung cancer
-
7:58
long-term survival with nivolumab ipilimumab in advanced nsclc | dr. sandeep ishi | crsf 2023
-
3:25
checkmate 816: neoadjuvant nivolumab chemotherapy for nsclc - onctalk lung 2023
-
0:57
lung cancer connect 2022 | dr venkat pradeep babu | welcome & introducation
-
24:30
s1 episode 4: managing lung cancer with neoadjuvant and adjuvant therapy
-
4:31
dr rushabh kothari | neoadjuvant nivolumab in early stage non stage non small cell lung cancer
-
15:34
optimizing neoadjuvant immunotherapy in nsclc by dr. kaushik | oncology perspective 2024
-
29:22
panel discussion dr tejinder singh choosing right vad in lung cancer patients
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc